Literature DB >> 16901264

Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential.

Mark Slevin1, Pat Kumar, John Gaffney, Shant Kumar, Jerzy Krupinski.   

Abstract

Recent developments in our understanding of the pathophysiological events that follow acute ischaemic stroke suggest an important role for angiogenesis which, through new blood vessel formation, results in improved collateral circulation and may impact on the medium-to-long term recovery of patients. Future treatment regimens may focus on optimization of this process in the ischaemic boundary zones or 'penumbra' region adjacent to the infarct, where partially affected neurons exposed to intermediate perfusion levels have the capability of survival if perfusion is maintained or normalized. In this review, we present evidence that angiogenesis is a key feature of ischaemic stroke recovery and neuronal post-stroke re-organization, examine the signalling mechanisms through which it occurs, and describe the therapeutic potential of treatments aimed at stimulating revascularization and neuroprotection after stroke.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16901264     DOI: 10.1042/CS20060049

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  60 in total

1.  Lymphocyte cell kinase activation mediates neuroprotection during ischemic preconditioning.

Authors:  Ok-Nam Bae; Krishnamurthy Rajanikant; Jiangyong Min; Jeremy Smith; Seung-Hoon Baek; Kelsey Serfozo; Siamak Hejabian; Ki Yong Lee; Mounzer Kassab; Arshad Majid
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

2.  MRI of blood-brain barrier permeability in cerebral ischemia.

Authors:  Quan Jiang; James R Ewing; Michael Chopp
Journal:  Transl Stroke Res       Date:  2012-03       Impact factor: 6.829

Review 3.  Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke.

Authors:  Ken Arai; Guang Jin; Deepti Navaratna; Eng H Lo
Journal:  FEBS J       Date:  2009-07-31       Impact factor: 5.542

4.  Genetic variant of BDNF (Val66Met) polymorphism attenuates stroke-induced angiogenic responses by enhancing anti-angiogenic mediator CD36 expression.

Authors:  Luye Qin; Eunhee Kim; Rajiv Ratan; Francis S Lee; Sunghee Cho
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

Review 5.  Applications and development of permeability imaging in ischemic stroke.

Authors:  Hui Chen; Guangming Zhu; Nan Liu; Ying Li; Yonghong Xia
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

6.  Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair.

Authors:  Nobutaka Horie; Marta P Pereira; Kuniyasu Niizuma; Guohua Sun; Hadar Keren-Gill; Angelo Encarnacion; Mehrdad Shamloo; Scott A Hamilton; Kewen Jiang; Stephen Huhn; Theo D Palmer; Tonya M Bliss; Gary K Steinberg
Journal:  Stem Cells       Date:  2011-02       Impact factor: 6.277

7.  Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies.

Authors:  Jens Minnerup; Sevgi Sevimli; Wolf-Rüdiger Schäbitz
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

Review 8.  New strategies for Alzheimer's disease and cognitive impairment.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

9.  Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention.

Authors:  Mark Slevin; Jerzy Krupinski; Lina Badimon
Journal:  J Angiogenes Res       Date:  2009-09-21

Review 10.  Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology.

Authors:  Kenneth Maiese; Jinling Hou; Zhao Zhong Chong; Yan Chen Shang
Journal:  ScientificWorldJournal       Date:  2009-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.